Remedy Pharmaceuticals Receives $400,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ab57ce04-9280-4062-86ad-1f3ee68ae91b&Preview=1
Date
9/30/2010
Company Name
Remedy Pharmaceuticals
Mailing Address
Undisclosed New York, NY 10001
Company Description
Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
Website
http://www.remedypharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$400,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Carrot Capital Healthcare Ventures